Clinical application of the cardioprotective effects of volatile anaesthetics: CON - Total intravenous anaesthesia or not total intravenous anaesthesia to anaesthetise a cardiac patient?

European Journal of Anaesthesiology

Volumn 28, Issue 9, 2011, Pages 623-627

  Van Rompaey, Nicolas ^a   Barvais, Luc ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

Cardiac surgery; Cardioprotection; Clinical outcome; Conditioning; Total intravenous anaesthesia; Volatile anaesthetics

Indexed keywords

INTRAVENOUS ANESTHETIC AGENT; PROPOFOL; REMIFENTANIL; SEVOFLURANE; VOLATILE AGENT;

CARDIAC PATIENT; CARDIOPULMONARY BYPASS; CLINICAL PRACTICE; CLINICAL TRIAL; HEART PROTECTION; HEART SURGERY; HUMAN; INTENSIVE CARE; INTRAVENOUS ANESTHESIA; MORBIDITY; NONHUMAN; REVIEW; SEDATION; SURVIVAL; TREATMENT FAILURE;

ANESTHETICS, INHALATION; ANIMALS; CARDIAC SURGICAL PROCEDURES; CARDIOTONIC AGENTS; HUMANS;

EID: 80052735457     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0b013e328349aca4     Document Type: Review

References (38)

1. De Hert SG, Turani F, Mathur S, Stowe DF. Cardioprotection with volatile anaesthetics: mechanisms and clinical implications. Anesth Analg 2005; 100:1584-1593. (Pubitemid 40712704)
2. Zaugg M, Lucchinetti E, Spahn DR, et al. Volatile anaesthetics mimic cardiac preconditioning by priming the activation of mitochondrial K(ATP) channels via multiple signaling pathways. Anesthesiology 2002; 97:4-14. (Pubitemid 34733916)
3. Hanouz J-L, Yvon A, Massetti M, et al. Mechanisms of desflurane-induced preconditioning in isolated human right atria in vitro. Anesthesiology 2002; 97:33-41. (Pubitemid 34733919)
4. Lange M, Smul TM, Blomeyer CA, et al. Role of the beta1-adrenergic pathway in anesthetic and ischemic preconditioning against myocardial infarction in the rabbit heart in vivo. Anesthesiology 2006; 105:503-510. (Pubitemid 44310433)
5. Lange M, Redel A, Smul TM, et al. Desflurane-induced preconditioning has a threshold that is lowered by repetitive application and is mediated by beta 2-adrenergic receptors. J Cardiothorac Vasc Anesth 2009; 23:607-613.
6. Mio Y, Bienengraeber MW, Marinovic J, et al. Age-related attenuation of isoflurane preconditioning in human atrial cardiomyocytes: roles for mitochondrial respiration and sarcolemmal adenosine triphosphate-sensitive potassium channel activity. Anesthesiology 2008; 108:612-620. (Pubitemid 351440581)
7. Sniecinski R, Liu H. Reduced efficacy of volatile anesthetic preconditioning with advanced age in isolated rat myocardium. Anesthesiology 2004; 100:589-597. (Pubitemid 38268877)
8. Riess ML, Camara AKS, Rhodes SS, et al. Increasing heart size and age attenuate anesthetic preconditioning in guinea pig isolated hearts. Anesth Analg 2005; 101:1572-1576. (Pubitemid 41720599)
9. Tanaka K, Kehl F, Gu W, et al. Isoflurane-induced preconditioning is attenuated by diabetes. Am J Physiol Heart Circ Physiol 2002; 282:2018-2023.
10. Kehl F, Krolikowski JG, Mraovic B, et al. Hyperglycemia prevents isoflurane-induced preconditioning against myocardial infarction. Anesthesiology 2002; 96:183-188. (Pubitemid 34032499)
11. Ferdinandy P, Schulz R, Baxter GF. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacol Rev 2007; 59:418-458.
12. Fellahi JL, Gue X, Philippe E, et al. Isoflurane may not influence postoperative cardiac troponin I release and clinical outcome in adult cardiac surgery. Eur J Anaesthesiol 2004; 21:688-693. (Pubitemid 39572291)
13. Piriou V, Mantz J, Goldfarb G, et al. Sevoflurane preconditioning at 1 MAC only provides limited protection in patients undergoing coronary artery bypass surgery: a randomized bi-centre trial. Br J Anaesth 2007; 99:624-631. (Pubitemid 351773223)
14. Bein B, Renner J, Caliebe D, et al. The effects of interrupted or continuous administration of sevoflurane on preconditioning before cardio-pulmonary bypass in coronary artery surgery: comparison with continuous propofol. Anaesthesia 2008; 63:1046-1055.
15. De Hert SG, Van der Linden PJ, Cromheecke S, et al. Choice of primary anesthetic regimen can influence intensive care unit length of stay after coronary surgery with cardiopulmonary bypass. Anesthesiology 2004; 101:9-20. (Pubitemid 38833257)
16. Scarci M, Fallouh HB, Young CP, Chambers DJ. Does intermittent cross-clamp fibrillation provide equivalent myocardial protection compared to cardioplegia in patients undergoing bypass graft revascularisation? Interact Cardiovasc Thorac Surg 2009; 9:872-878.
17. Barvais L, Rausin I, Glen JB, et al. Administration of propofol by target-controlled infusion in patients undergoing coronary artery surgery. J Cardiothorac Vasc Anesth 1996; 10:877-883. (Pubitemid 26422481)
18. Malagon I, Hogenbirk K, van Pelt J, et al. Effect of three different anaesthetic agents on the postoperative production of cardiac troponin T in paediatric cardiac surgery. Br J Anaesth 2005; 94:805-809. (Pubitemid 40753998)
19. Landoni G, Calabrò MG, Marchetti C, et al. Desflurane versus propofol in patients undergoing mitral valve surgery. J Cardiothorac Vasc Anesth 2007; 21:672-677. (Pubitemid 47464944)
20. Cromheecke S, Pepermans V, Hendrickx E, et al. Cardioprotective properties of sevoflurane in patients undergoing aortic valve replacement with cardiopulmonary bypass. Anesth Analg 2006; 103:289-296. (Pubitemid 44140622)
21. Yu CH, Beattie WS. The effects of volatile anesthetics on cardiac ischemic complications and mortality in CABG: a meta-analysis. Can J Anaesth 2006; 53:906-918. (Pubitemid 44696515)
22. Symons JA, Myles PS. Myocardial protection with volatile anaesthetic agents during coronary artery bypass surgery: a meta-analysis. Br J Anaesth 2006; 97:127-136. (Pubitemid 44295694)
23. Landoni G, Biondi-Zoccai GGL, Zangrillo A, et al. Desflurane and sevoflurane in cardiac surgery: a meta-analysis of randomized clinical trials. J Cardiothorac Vasc Anesth 2007; 21:502-511. (Pubitemid 47135634)
24. Jakobsen CJ, Berg H, Hindsholm KB, et al. The influence of propofol versus sevoflurane anaesthesia on outcome in 10535 cardiac surgical procedures. J Cardiothorac Vasc Anesth 2007; 21:664-671. (Pubitemid 47464955)
25. Bignami E, Biondi-Zoccai G, Landoni G, et al. Volatile anesthetics reduce mortality in cardiac surgery. J Cardiothorac Vasc Anesth 2009; 23:594-599.
26. Flier S, Post J, Concepcion AN, et al. Influence of propofol-opioid vs isoflurane-opioid anaesthesia on postoperative troponin release in patients undergoing coronary artery bypass grafting. Br JAnaesth 2010; 105:122-130.
27. De Hert SG, Vlasselaers D, Barbé R, et al. A comparison of volatile and non volatile agents for cardioprotection during on-pump coronary surgery. Anaesthesia 2009; 64:953-960.
28. Hellström J, Owall A, Bergström J, Sackey PV. Cardiac outcome after sevoflurane versus propofol sedation following coronary bypass surgery: a pilot study. Acta Anaesthesiol Scand 2011; 55:460-467.
29. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery. J Am Coll Cardiol 2007; 50:1707-1732.
30. Kevin LG, Novalija E, Stowe DF. Reactive oxygen species as mediators of cardiac injury and protection: the relevance to anesthesia practice. Anesth Analg 2005; 101:1275-1287. (Pubitemid 41531857)
31. Ebel D, Schlack W, Comfère T, et al. Effect of propofol on reperfusion injury after regional ischaemia in the isolated rat heart. Br J Anaesth 1999; 83:903-908.
32. Hirata N, Kanaya N, Kamada N, et al. Differential effects of propofol and sevoflurane on ischemia-induced ventricular arrhythmias and phosphorylated connexin 43 protein in rats. Anesthesiology 2009; 110:50-57.
33. Sayin MM, Ozatamer O, Taşöz R, et al. Propofol attenuates myocardial lipid peroxidation during coronary artery bypass grafting surgery. Br J Anaesth 2002; 89:242-246.
34. Xia Z, Huang Z, Ansley DM. Large-dose propofol during cardiopulmonary bypass decreases biochemical markers of myocardial injury in coronary surgery patients: a comparison with isoflurane. Anesth Analg 2006; 103:527-532. (Pubitemid 44542898)
35. Corcoran TB, Engel A, Sakamoto H, et al. The effects of propofol on neutrophil function, lipid peroxidation and inflammatory response during elective coronary artery bypass grafting in patients with impaired ventricular function. Br J Anaesth 2006; 97:825-831. (Pubitemid 44823668)
36. Krzych LJ, Szurlej D, Bochenek A. Rationale for propofol use in cardiac surgery. J Cardiothorac Vasc Anesth 2009; 23:878-885.
37. Yu CK, Li Y-H, Wong GTC, et al. Remifentanil preconditioning confers delayed cardioprotection in the rat. Br J Anaesth 2007; 99:632-638. (Pubitemid 351773220)
38. Wong GT, Ling Ling J, Irwin MG. Activation of central opioid receptors induces cardioprotection against ischemia-reperfusion injury. Anesth Analg 2010; 111:24-28.